Well Lipscombe sees Ozempic and semaglutides in general as being a positive for us but maybe the funds are thinking that diabetes is a solved problem. I don't mind if they take a while to be disavowed of that view and I can accumulate a few more
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)